Literature DB >> 18435760

Alternative binding proteins get mature: rivalling antibodies.

Harald Kolmar1, Arne Skerra.   

Abstract

Mesh：

Substances：

Year:  2008        PMID： 18435760     DOI： 10.1111/j.1742-4658.2008.06437.x

Source DB:  PubMed          Journal:  FEBS J        ISSN： 1742-464X            Impact factor:   5.542


× No keyword cloud information.
  11 in total

Review 1.  Engineered CH2 domains (nanoantibodies).

Authors:  Dimiter S Dimitrov
Journal:  MAbs       Date:  2009 Jan-Feb       Impact factor: 5.857

2.  Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor.

Authors:  Rui Gong; Yanping Wang; Yang Feng; Qi Zhao; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

Review 3.  Using backbone-cyclized Cys-rich polypeptides as molecular scaffolds to target protein-protein interactions.

Authors:  Dipankar Chaudhuri; Teshome Aboye; Julio A Camarero
Journal:  Biochem J       Date:  2019-01-11       Impact factor: 3.857

4.  A large human domain antibody library combining heavy and light chain CDR3 diversity.

Authors:  Weizao Chen; Zhongyu Zhu; Yang Feng; Dimiter S Dimitrov
Journal:  Mol Immunol       Date:  2009-11-01       Impact factor: 4.407

5.  Expression, purification, and characterization of engineered antibody CH2 and VH domains.

Authors:  Rui Gong; Weizao Chen; Dimiter S Dimitrov
Journal:  Methods Mol Biol       Date:  2012

Review 6.  Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery.

Authors:  Andrew Gould; Yanbin Ji; Teshome L Aboye; Julio A Camarero
Journal:  Curr Pharm Des       Date:  2011-12       Impact factor: 3.116

Review 7.  Cyclotides, a promising molecular scaffold for peptide-based therapeutics.

Authors:  Krishnappa Jagadish; Julio A Camarero
Journal:  Biopolymers       Date:  2010       Impact factor: 2.505

8.  Structure-function studies of an engineered scaffold protein derived from stefin A. I: Development of the SQM variant.

Authors:  Toni Hoffmann; Lukas Kurt Josef Stadler; Michael Busby; Qifeng Song; Anthony T Buxton; Simon D Wagner; Jason J Davis; Paul Ko Ferrigno
Journal:  Protein Eng Des Sel       Date:  2010-02-23       Impact factor: 1.650

9.  Engineered human antibody constant domains with increased stability.

Authors:  Rui Gong; Bang K Vu; Yang Feng; DaRue A Prieto; Marzena A Dyba; Joseph D Walsh; Ponraj Prabakaran; Timothy D Veenstra; Sergey G Tarasov; Rieko Ishima; Dimiter S Dimitrov
Journal:  J Biol Chem       Date:  2009-03-23       Impact factor: 5.157

Review 10.  Protein microarrays: novel developments and applications.

Authors:  Luis Berrade; Angie E Garcia; Julio A Camarero
Journal:  Pharm Res       Date:  2010-11-30       Impact factor: 4.200
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.